U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3108131081Determining the Depth of Endotracheal Tube InsertionCompletedHas ResultsEndotracheal Intubation|Individualized Depth of Endotracheal Intubationhttps://ClinicalTrials.gov/show/NCT02158247
3108231082Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckRecruitingNo Results AvailableSquamous Cell Carcinoma of the Head and NeckDrug: Cisplatin|Radiation: Stereotactic Body Radiation Therapy (SBRT)https://ClinicalTrials.gov/show/NCT02158234
3108331083PACAP Induced Migraine Attacks in Patients With High and Low Genetic LoadCompletedNo Results AvailableMigraine Without AuraDrug: PACAPhttps://ClinicalTrials.gov/show/NCT02158221
3108431084Study of the T CD8 Immune Response in Horton's DiseaseRecruitingNo Results AvailableHorton's DiseaseOther: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment|Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment|Other: Blood sample drawn into a 5 mL dry tube|Other: 16 blood samples drawn into 6 mL heparinized tubeshttps://ClinicalTrials.gov/show/NCT02158208
3108531085Immunopathology of Autoimmune Hemolytic AnemiaRecruitingNo Results AvailableAutoimmune Hemolytic AnemiaBiological: blood sampleshttps://ClinicalTrials.gov/show/NCT02158195
3108631086Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal BleedingRecruitingNo Results AvailableHepatic EncephalopathyDrug: Lactulose|Drug: L-ornithine L-aspartate|Drug: Rifaximin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02158182
3108731087Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and HaematologyCompletedNo Results AvailableChemotherapy-induced Anemiahttps://ClinicalTrials.gov/show/NCT02158169
3108831088Effect of Aerobic Training in Patients With Oculopharyngeal Muscular DystrophyRecruitingNo Results AvailableOculopharyngeal Muscular DystrophyBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT02158156
3108931089A Single High-dose Oral Supplement of Vitamin D in Young ChineseCompletedNo Results AvailableVitamin D DeficiencyDietary Supplement: vitamin D3https://ClinicalTrials.gov/show/NCT02158143
3109031090Effects of Aerobic Exercise DetrainingRecruitingNo Results AvailableMotor Activity|Body Weight|Obesityhttps://ClinicalTrials.gov/show/NCT02158130
3109131091Bioavailability of a New Formulation of Nasal Naloxone for Prehospital UseCompletedNo Results AvailableDrug OverdoseDrug: nasal naloxonehttps://ClinicalTrials.gov/show/NCT02158117
3109231092Soreness After Deep Dry Needling of One Latent Myofascial Trigger PointCompletedNo Results AvailablePain After Dry NeedlingProcedure: Deep dry needlinghttps://ClinicalTrials.gov/show/NCT02158104
3109331093A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLLRecruitingNo Results AvailableChronic Lymphocytic LeukemiaDrug: IPI-145|Drug: Fludarabine|Drug: Cyclophosphamide|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT02158091
3109431094A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes MellitusTerminatedNo Results AvailableType 2 Diabetes MellitusDevice: PaQ® Insulin Delivery Devicehttps://ClinicalTrials.gov/show/NCT02158078
3109531095Impact of "Telecoaching Program" on Physical Activity in Patients With COPDCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveOther: Coaching programhttps://ClinicalTrials.gov/show/NCT02158065
3109631096Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal DiseaseRecruitingNo Results AvailableMultiple Myeloma|Bone Marrow Failure Syndromes|Hemoglobinopathies|AML|ALL|Myeloid Leukemia, Chronic|NHL|HL|MDS|Amyloidosis|MyelofibrosisDrug: Tacrolimus|Drug: Anti-thymocyte globulin|Procedure: Kidney transplant|Drug: Bone marrow transplant from a related donor|Radiation: Total body irradiation 400 centigray (200 cGy X 2)https://ClinicalTrials.gov/show/NCT02158052
3109731097Endoscopic Ultrasound-guided Ethanol Injection of Pancreatic Cystic NeoplasmsActive, not recruitingNo Results AvailableNeoplasms, Cystic, Mucinous, and SerousDrug: EUS-guided ethanol injectionhttps://ClinicalTrials.gov/show/NCT02158039
3109831098Evaluation of the Role of Follicular Sensitivity Index in the Prediction of Pregnancy in Women Undergoing ICSI/IVF Without Polycystic Ovarian SyndromeRecruitingNo Results AvailableSubfertility|Assisted Reproductionhttps://ClinicalTrials.gov/show/NCT02158026
3109931099Treatment Of Chronic Anal FissureRecruitingNo Results AvailableChronic Anal FissureOther: Levorag Emulgel|Drug: Diltiazemhttps://ClinicalTrials.gov/show/NCT02158013
3110031100Aspiration of Excessive Endometrial Fluid at the Day of Ovum Retrieval Plus Diosmin in (ICSI) CyclesCompletedNo Results AvailableInfertilityOther: group Ahttps://ClinicalTrials.gov/show/NCT02158000
3110131101Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseRecruitingNo Results AvailableTelangiectasia, Hereditary HemorrhagicDrug: bevacuzimab sprayhttps://ClinicalTrials.gov/show/NCT02157987
3110231102Liver and Fat Regulation in Overweight Adolescent GirlsRecruitingNo Results AvailableHepatic Steatosis|Polycystic Ovarian Syndrome|Obesityhttps://ClinicalTrials.gov/show/NCT02157974
3110331103Doctor's Health - Health Behavior of General Practitioners in GermanyRecruitingNo Results AvailableChronic Diseases|Chronic Illnesseshttps://ClinicalTrials.gov/show/NCT02157961
3110431104A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With OsteoporosisCompletedNo Results AvailablePostmenopausal OsteoporosisDrug: Denosumab (CP2)|Drug: Denosumab (CP4)https://ClinicalTrials.gov/show/NCT02157948
3110531105Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary DiseaseActive, not recruitingNo Results AvailableCOPD PatientsDrug: Symbicort|Drug: Formoterol turbohaler|Other: Placebo for Symbicort pMDI|Other: Placebo for Formoterol Turbohalerhttps://ClinicalTrials.gov/show/NCT02157935
3110631106A Phase IIb Study of OligoG in Subjects With Cystic FibrosisRecruitingNo Results AvailableCystic FibrosisDrug: alginate oligosaccharidehttps://ClinicalTrials.gov/show/NCT02157922
3110731107DW Evaluation of Lotrafilcon B Lenses in a Modified DesignCompletedHas ResultsMyopiaDevice: Lotrafilcon B sphere modified design contact lenses|Device: Lotrafilcon B sphere contact lenseshttps://ClinicalTrials.gov/show/NCT02157909
3110831108Vascular Endothelial Growth Factor and Endostatin in Angiogenesis After Acute Ischemic StrokeCompletedNo Results AvailableAcute Ischemic Strokehttps://ClinicalTrials.gov/show/NCT02157896
3110931109Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medicine (Such aActive, not recruitingNo Results AvailableAdvanced Non Small Cell Lung Cancer|Advanced (Inoperable) Non Small Cell Lung CancerProcedure: Pharmacokinetic sampling|Drug: AZD9291|Drug: Itraconazolehttps://ClinicalTrials.gov/show/NCT02157883
3111031110A Randomized Study of Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian CancerWithdrawnNo Results AvailableOvarian CancerBiological: Intraperitoneal tgDCC-E1A|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT02157870

* Görseller ve İçerik tekif hakkına sahip olabilir